The Ministry of Health in Jujuy announced on April 8 that the province currently has 34 confirmed cases of chikungunya, along with 14 probable cases awaiting laboratory confirmation. Secretary Javier Cadar said there are no patients hospitalized and no fatalities have been reported so far.
Cadar said, “Estamos realizando el tratamiento correspondiente tanto a los casos confirmados como a los probables de forma conjunta. Afortunadamente, la mayorÃa evoluciona favorablemente y sin complicaciones graves.” The majority of those affected are recovering well without serious complications.
According to the ministry, Aguas Calientes is the most affected area with 22 confirmed and eight probable cases. Other localities include Perico with four cases; Caimancito with three confirmed and three probable; San Salvador de Jujuy (Alto Comedero sector) with two confirmed and three probable; and one case each in San Pedro, Libertador General San MartÃn, and Yuto.
Cadar explained that the most common symptoms observed are intense joint pain (arthralgia), muscle pain (myalgia), and fever. Authorities expect mosquito activity to decrease as temperatures drop but continue to stress preventive measures such as using repellents, mosquito nets, and wearing long-sleeved clothing.
In addition to vector-borne illnesses, Cadar noted ongoing circulation of influenza (flu), parainfluenza, and COVID-19 in the region. He recommended frequent hand washing, ventilating rooms, and wearing masks if symptomatic to prevent widespread transmission. He also advised people experiencing fever or general discomfort to visit their nearest health center for differential diagnosis between dengue/chikungunya or respiratory infections like influenza type A (H3N2).
The ministry reported that after national delays in supply delivery, Jujuy received a new batch of flu vaccines for immediate distribution across the province during April and May. Priority groups for vaccination include healthcare workers, adults over 65 years old, children aged six to twenty-four months—where coverage rates are high—and individuals with chronic conditions who have medical indications.
